Late mortality after orthotopic liver transplantation

John M. Rabkin, Violetta De La Melena, Susan Orloff, Christopher Corless, Hugo R. Rosen, Ali J. Olyaei

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Background: Mortality within the first year after orthotopic liver transplantation (OLTx) is usually due to infection or allograft failure. Late complications leading to death after OLTx have not been extensively evaluated. The aim of this study was to determine the incidence of late mortality and to identify the most common causes and risk factors associated with late mortality after OLTx. Methods: A total of 479 OLTx were performed in 459 patients (320 males, 139 females; mean age 47 years, range 13 to 69) between September 1991 and April 2000. All patient deaths among liver transplant recipients who survived more than 1 year after transplantation (follow-up mean 3.4 years, median 3, range 1 to 8.6) were reviewed. Results: In all, 122 allografts (24%) were lost in 109 patients during the study period (24%). Seventy-five allografts were lost in 69 patients by 1 year (15%). Forty-seven allografts were lost in 40 patients who survived at least 1 year (9.6%). Actuarial survivals at 2 years, 5 years, and 9 years were 95%, 85%, and 80%, respectively (based on 100% survival at 1 year). The causes of the late mortality were malignancy (9 patients), disease recurrence (8), late infection (6), renal failure complications (5), cardiovascular complications (4), chronic rejection (3), gastrointestinal hemorrhage (2), medication noncompliance (1), and unknown (2). Conclusions: Malignancy and disease recurrence are the major causes of late mortality among adult OLTx recipients. Pharmacologic immunosuppression is associated with many of the causes of late mortality. Advances in immunosuppression with less toxicity may improve long-term survival after OLTx.

Original languageEnglish (US)
Pages (from-to)475-479
Number of pages5
JournalAmerican Journal of Surgery
Volume181
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Liver Transplantation
Allografts
Mortality
Immunosuppression
Survival
Recurrence
Gastrointestinal Hemorrhage
Medication Adherence
Infection
Renal Insufficiency
Neoplasms
Transplantation
Liver
Incidence

Keywords

  • Allograft failure
  • Late mortality
  • Liver transplantation
  • Survival

ASJC Scopus subject areas

  • Surgery

Cite this

Late mortality after orthotopic liver transplantation. / Rabkin, John M.; De La Melena, Violetta; Orloff, Susan; Corless, Christopher; Rosen, Hugo R.; Olyaei, Ali J.

In: American Journal of Surgery, Vol. 181, No. 5, 2001, p. 475-479.

Research output: Contribution to journalArticle

Rabkin, John M. ; De La Melena, Violetta ; Orloff, Susan ; Corless, Christopher ; Rosen, Hugo R. ; Olyaei, Ali J. / Late mortality after orthotopic liver transplantation. In: American Journal of Surgery. 2001 ; Vol. 181, No. 5. pp. 475-479.
@article{37254b32addb4b59bc3c7a1f4f037e9d,
title = "Late mortality after orthotopic liver transplantation",
abstract = "Background: Mortality within the first year after orthotopic liver transplantation (OLTx) is usually due to infection or allograft failure. Late complications leading to death after OLTx have not been extensively evaluated. The aim of this study was to determine the incidence of late mortality and to identify the most common causes and risk factors associated with late mortality after OLTx. Methods: A total of 479 OLTx were performed in 459 patients (320 males, 139 females; mean age 47 years, range 13 to 69) between September 1991 and April 2000. All patient deaths among liver transplant recipients who survived more than 1 year after transplantation (follow-up mean 3.4 years, median 3, range 1 to 8.6) were reviewed. Results: In all, 122 allografts (24{\%}) were lost in 109 patients during the study period (24{\%}). Seventy-five allografts were lost in 69 patients by 1 year (15{\%}). Forty-seven allografts were lost in 40 patients who survived at least 1 year (9.6{\%}). Actuarial survivals at 2 years, 5 years, and 9 years were 95{\%}, 85{\%}, and 80{\%}, respectively (based on 100{\%} survival at 1 year). The causes of the late mortality were malignancy (9 patients), disease recurrence (8), late infection (6), renal failure complications (5), cardiovascular complications (4), chronic rejection (3), gastrointestinal hemorrhage (2), medication noncompliance (1), and unknown (2). Conclusions: Malignancy and disease recurrence are the major causes of late mortality among adult OLTx recipients. Pharmacologic immunosuppression is associated with many of the causes of late mortality. Advances in immunosuppression with less toxicity may improve long-term survival after OLTx.",
keywords = "Allograft failure, Late mortality, Liver transplantation, Survival",
author = "Rabkin, {John M.} and {De La Melena}, Violetta and Susan Orloff and Christopher Corless and Rosen, {Hugo R.} and Olyaei, {Ali J.}",
year = "2001",
doi = "10.1016/S0002-9610(01)00595-5",
language = "English (US)",
volume = "181",
pages = "475--479",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Late mortality after orthotopic liver transplantation

AU - Rabkin, John M.

AU - De La Melena, Violetta

AU - Orloff, Susan

AU - Corless, Christopher

AU - Rosen, Hugo R.

AU - Olyaei, Ali J.

PY - 2001

Y1 - 2001

N2 - Background: Mortality within the first year after orthotopic liver transplantation (OLTx) is usually due to infection or allograft failure. Late complications leading to death after OLTx have not been extensively evaluated. The aim of this study was to determine the incidence of late mortality and to identify the most common causes and risk factors associated with late mortality after OLTx. Methods: A total of 479 OLTx were performed in 459 patients (320 males, 139 females; mean age 47 years, range 13 to 69) between September 1991 and April 2000. All patient deaths among liver transplant recipients who survived more than 1 year after transplantation (follow-up mean 3.4 years, median 3, range 1 to 8.6) were reviewed. Results: In all, 122 allografts (24%) were lost in 109 patients during the study period (24%). Seventy-five allografts were lost in 69 patients by 1 year (15%). Forty-seven allografts were lost in 40 patients who survived at least 1 year (9.6%). Actuarial survivals at 2 years, 5 years, and 9 years were 95%, 85%, and 80%, respectively (based on 100% survival at 1 year). The causes of the late mortality were malignancy (9 patients), disease recurrence (8), late infection (6), renal failure complications (5), cardiovascular complications (4), chronic rejection (3), gastrointestinal hemorrhage (2), medication noncompliance (1), and unknown (2). Conclusions: Malignancy and disease recurrence are the major causes of late mortality among adult OLTx recipients. Pharmacologic immunosuppression is associated with many of the causes of late mortality. Advances in immunosuppression with less toxicity may improve long-term survival after OLTx.

AB - Background: Mortality within the first year after orthotopic liver transplantation (OLTx) is usually due to infection or allograft failure. Late complications leading to death after OLTx have not been extensively evaluated. The aim of this study was to determine the incidence of late mortality and to identify the most common causes and risk factors associated with late mortality after OLTx. Methods: A total of 479 OLTx were performed in 459 patients (320 males, 139 females; mean age 47 years, range 13 to 69) between September 1991 and April 2000. All patient deaths among liver transplant recipients who survived more than 1 year after transplantation (follow-up mean 3.4 years, median 3, range 1 to 8.6) were reviewed. Results: In all, 122 allografts (24%) were lost in 109 patients during the study period (24%). Seventy-five allografts were lost in 69 patients by 1 year (15%). Forty-seven allografts were lost in 40 patients who survived at least 1 year (9.6%). Actuarial survivals at 2 years, 5 years, and 9 years were 95%, 85%, and 80%, respectively (based on 100% survival at 1 year). The causes of the late mortality were malignancy (9 patients), disease recurrence (8), late infection (6), renal failure complications (5), cardiovascular complications (4), chronic rejection (3), gastrointestinal hemorrhage (2), medication noncompliance (1), and unknown (2). Conclusions: Malignancy and disease recurrence are the major causes of late mortality among adult OLTx recipients. Pharmacologic immunosuppression is associated with many of the causes of late mortality. Advances in immunosuppression with less toxicity may improve long-term survival after OLTx.

KW - Allograft failure

KW - Late mortality

KW - Liver transplantation

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0034969097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034969097&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(01)00595-5

DO - 10.1016/S0002-9610(01)00595-5

M3 - Article

C2 - 11448447

AN - SCOPUS:0034969097

VL - 181

SP - 475

EP - 479

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 5

ER -